Table 2 Univariate and multivariate cox proportional hazards regression analysis for COVID-19 patient survival based on demographics, lipid profiles, and comorbidities.
From: Association between lipid profile and clinical outcomes in COVID-19 patients
Variables | COVID-19 severity | COVID-19 mortality | ||||
|---|---|---|---|---|---|---|
Log (OR)a | 95% CIa | p-value | Log (OR)a | 95% CIa | p-value | |
Age | 0.08 | 0.03, 0.13 | 0.003 | 0.09 | 0.03, 0.15 | 0.003 |
Sex | 0.5 | |||||
Female | – | – | – | – | ||
Male | 0.20 | − 0.99, 1.4 | 0.7 | 0.50 | − 0.80, 1.9 | |
Chol ≥ 99.5 | 0.91 | − 0.79, 2.8 | 0.3 | |||
LDL-c ≤ 48.5 | 2.2 | 0.53, 4.2 | 0.015 | |||
HDL-c ≤ 25.5 | 1.1 | − 0.07, 2.4 | 0.073 | |||
Tryg ≥ 139.5 | 1.0 | − 0.09, 2.3 | 0.082 | |||
Diabetes | 0.5 | |||||
No | – | – | – | – | ||
Yes | 0.08 | − 1.0, 1.2 | 0.9 | − 0.45 | − 1.8, 0.80 | |
Hypertension | 0.014 | |||||
No | – | – | – | – | ||
Yes | 1.6 | 0.33, 3.1 | 0.020 | 1.8 | 0.43, 3.3 | |
Obesity | 0.6 | |||||
No | – | – | – | – | ||
Yes | 0.69 | − 0.81, 2.2 | 0.4 | 0.51 | − 1.2, 2.3 | |
Chol ≥ 138.5 | 3.1 | 1.3, 5.3 | 0.002 | |||
LDL-c ≤ 44.5 | 2.6 | 0.97, 4.5 | 0.004 | |||
HDL-c ≤ 24.5 | 2.6 | 1.0, 4.5 | 0.003 | |||
Tryg ≥ 156.5 | 0.65 | − 0.72, 2.1 | 0.4 | |||
